Skip Ribbon Commands Skip to main content

Hyaluronic acid - Hyasis®


Novozymes is redefining hyaluronic acid (HA) with Hyasis, the next generation of high-quality HA based on the safe bacteria Bacillus subtilis, expanding the number of possible applications of HA in medical device and pharma products:

Novozymes is setting new standards for HA, by offering:

  • Safety – no animal-derived raw materials, organic solvents or toxins

  • Consistency – high batch-to-batch consistency, targeted molecular weight and narrow polydispersity

  • Performance – superior heat stability and up to 5 x faster dissolving time

Hyasis® Link is the new state-of-the-art proprietary crosslinking technology for modifying the properties of HA and preparing HA hydrogels, which are versatile in application and well tolerated.

Novozymes Biopharma

Novozymes Biopharma is a world leading provider of high-quality, safe, biological based solutions used by pharma and device companies to improve quality of life.

Copyright © 2014 Novozymes. All rights reserved.